As withdrawal of Clinical Pathology Accreditation standards looms, Siemens asked experts at its chemistry and immunoassay user group to explore the changes ahead.
Medical laboratories are essential to the provision of high-quality care, playing a significant part in facilitating the patient pathway. Ensuring laboratory systems and processes are aligned and fit for purpose; the ISO 15189 standards will play an increasingly large part in certifying quality and competence.
With recent developments in how laboratories are assessed against ISO 15189 in the UK, Clinical Pathology Accreditation (CPA) accredited laboratories will now transfer to United Kingdom Accreditation Service (UKAS) accreditation as part of a strategy to contribute to the modernisation of pathology services.
In order to understand the impact of the change and the new requirements involved, Ian Rothnie, (Aberdeen Royal Infirmary), a UKAS technical expert recently chaired a two-day Siemens Healthcare Diagnostics Chemistry and Immunoassay User Group meeting, which was attended by biomedical scientists and laboratory managers from across the UK.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.